- Home
- ZEPP vs SER Comparison
ZEPP vs SER Comparison
Compare ZEPP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- SER
- Stock Information
- Founded
- ZEPP 2013
- SER 2017
- Country
- ZEPP Netherlands
- SER United States
- Employees
- ZEPP N/A
- SER N/A
- Industry
- ZEPP Computer Manufacturing
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- SER Health Care
- Exchange
- ZEPP Nasdaq
- SER Nasdaq
- Market Cap
- ZEPP 35.1M
- SER 56.5M
- IPO Year
- ZEPP N/A
- SER 2018
- Fundamental
- Price
- ZEPP $2.90
- SER $5.80
- Analyst Decision
- ZEPP
- SER Strong Buy
- Analyst Count
- ZEPP 0
- SER 1
- Target Price
- ZEPP N/A
- SER $11.00
- AVG Volume (30 Days)
- ZEPP 19.6K
- SER 16.6K
- Earning Date
- ZEPP 08-20-2025
- SER 08-08-2025
- Dividend Yield
- ZEPP N/A
- SER N/A
- EPS Growth
- ZEPP N/A
- SER N/A
- EPS
- ZEPP N/A
- SER N/A
- Revenue
- ZEPP $181,183,000.00
- SER $51,000.00
- Revenue This Year
- ZEPP $758.69
- SER N/A
- Revenue Next Year
- ZEPP N/A
- SER N/A
- P/E Ratio
- ZEPP N/A
- SER N/A
- Revenue Growth
- ZEPP N/A
- SER N/A
- 52 Week Low
- ZEPP $2.06
- SER $3.81
- 52 Week High
- ZEPP $4.38
- SER $11.57
- Technical
- Relative Strength Index (RSI)
- ZEPP 58.03
- SER 57.53
- Support Level
- ZEPP $2.50
- SER $5.50
- Resistance Level
- ZEPP $2.80
- SER $6.29
- Average True Range (ATR)
- ZEPP 0.16
- SER 0.52
- MACD
- ZEPP 0.04
- SER 0.03
- Stochastic Oscillator
- ZEPP 75.45
- SER 74.44
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.